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Abstract  15 
Cryptosporidium is a gastrointestinal parasite that is recognised as a significant cause  16 
of non-viral diarrhea in both developing and industrialised countries. In the present study, a  17 
longitudinal analysis of 248 faecal specimens from Australian humans with gastrointestinal  18 
symptoms from 2005 to 2008 was conducted. Sequence analysis of the 18S rRNA gene locus  19 
and the 60 kDa glycoprotein (gp60) gene locus revealed that 195 (78.6%) of the cases were  20 
due  to  infection  with  C.  hominis,  49  (19.8%)  with  C.  parvum  and  four  (1.6%)  with  C.  21 
meleagridis. A total of eight gp60 subtype families were identified; five C. hominis subtype  22 
families (Ib, Id, Ie, If and Ig), and two C. parvum subtype families (IIa and IId). The Id  23 
subtype  family  was  the  most  common  C.  hominis  subtype  family  identified  in  45.7%  of  24 
isolates, followed by the Ig subtype family (30.3%) and the Ib subtype family (20%). The  25 
most common C. parvum subtype was IIaA18G3R1, identified in 65.3% of isolates. The more  26 
rare zoonotic IId A15G1 subtype was identified in one isolate. Statistical analysis showed that  27 
the  Id  subtype  was  associated  with  abdominal  pain  (p<0.05)  and  that  in  sporadic  28 
cryptosporidiosis, children aged 5 and below were 1.91 times and 1.88 times more likely to be  29 
infected with subtype Id (RR1.91; 95% CI, 1.7-2.89; p<0.05) and Ig (RR 1.88; 95% CI, 1.10- 30 
3.24; p<0.05) compared to children aged 5 and above. A subset of isolates were also analysed  31 
at  the  variable  CP47  and  MSC6-7  gene  loci.  Findings  from  this  study  suggest  that  32 
anthroponotic transmission of Cryptosporidium plays a major role in the epidemiology of  33 
cryptosporidiosis in Western Australian humans.   34 
    35 
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1. Introduction  38 
    39 
Cryptosporidiosis is a gastrointestinal disease in humans and animals caused by the  40 
protozoan parasite Cryptosporidium. The disease, characterised by self-limiting diarrhoea in  41 
immunocompetent  individuals,  may  be  chronic  and  life-threatening  to  those  that  are  42 
immunocompromised  (Hunter  and  Nichols,  2002;  Hunter  et  al.,  2007).  Of  the  21  valid  43 
Cryptosporidium  species,  C.  hominis  and  C.  parvum  are  responsible  for  the  majority  of  44 
infections in humans, although C. meleagridis C. felis and C. canis and to a lesser extent, C.  45 
muris, C. suis and several genotypes have also been reported in humans (Xiao and Fayer,  46 
2008; Xiao, 2010).   47 
  Oocysts of most Cryptosporidium spp. are morphologically similar and therefore they  48 
can only be distinguished by molecular means, usually at conserved loci such as the 18S  49 
rRNA or the actin gene. Several fingerprinting tools have been developed to examine the  50 
population  structure  and  transmission  dynamics  of  C.  parvum  and  C.  hominis  including  51 
sequencing of the 60-kDa glycoprotein (gp60)-gene, which has shown to be useful in tracking  52 
source of infection of C. parvum and C. hominis (Strong et al., 2000; Mallon et al., 2003a;  53 
Peng et al., 2003a; Widmer et al., 2004; Xiao and Ryan, 2004; Sulaiman et al., 2005; Alves et  54 
al., 2006; Feltus et al., 2006; Gatei et al., 2006; Trotz-Williams et al., 2006; Leoni et al., 2007;  55 
Thompson et al., 2007; Ng et al., 2008; O'Brien et al., 2008).  56 
Cryptosporidiosis was listed as a nationally notifiable disease in Australia in 2001  57 
(Communicable Disease Surveillance: Highlights for 2
nd quarter 2001, 2001) and since then,  58 
incidence of the disease in Australia has been increasing steadily with 2009 recording the  59 
highest number of cases nationally compared to that of the previous five  years (National  60 
Notifiable Diseases  Surveillance System  (NNDSS), http://www.health.gov.au).  In Western  61 
Australia (WA), 625 cases of cryptosporidiosis were notified in 2007, which was almost 3  62 
times that of notification rates for the previous 4 years.   63 ACCEPTED MANUSCRIPT 
  4 
Molecular studies of Cryptosporidium species infecting humans in WA, New South  64 
Wales  (NSW),  Victoria  (VIC)  and  South  Australia  (SA)  have  identified  three  65 
Cryptosporidium species; C. hominis, C. parvum and C. meleagridis with C. hominis being  66 
the most frequently identified species of the three (Robertson et al., 2002; Chalmers et al.,  67 
2005; Jex et al., 2007; Ng et al., 2008; O’Brien et al., 2008, Jex et al., 2008; Alagappan et al.,  68 
2008; Waldron et al., 2009a; 2009b). The published studies to date however were conducted  69 
on  limited  numbers  of  sporadic  cases  of  cryptosporidiosis  and  no  longitudinal  molecular  70 
studies of cryptosporidiosis have been conducted in Australia. The aim of the present study  71 
therefore, was to examine samples from sporadic cases of cryptosporidiosis in WA humans  72 
over a three-year period (May 2005-March 2008) to identify the species and subtypes of  73 
Cryptosporidium  causing  sporadic  human  cryptosporidiosis  to  better  understand  the  74 
transmission dynamics and distribution of the parasite in WA.   75 
  76 
2. Materials and methods  77 
  78 
2.1. Specimens and DNA extraction  79 
  80 
A total of 254 microscopy positive human faecal specimens from sporadic cases of  81 
cryptosporidiosis were collected from various pathology centres in WA from May 2005 to  82 
March  2008.  All  samples  were  stored  at  4°C  prior  to  molecular  analysis.  Patient  83 
epidemiological information for most of the specimens were collected (age, n=234; location,  84 
n=230; symptoms or clinical signs, n=209; collection date, n=234). Total DNA was extracted  85 
using a QIAmp DNA Stool Kit (Qiagen, Germany).   86 
  87 ACCEPTED MANUSCRIPT 
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2.2. PCR Amplification and DNA sequencing  88 
  89 
Initial  genotyping  of  the  samples  were  carried  out  by  PCR-RFLP  of  an  ~830bp  90 
fragment of the Cryptosporidium 18S gene locus as described by Xiao et al., (2001), using  91 
restriction analysis of the PCR product by the VspI (Promega, USA) to discriminate between  92 
C. hominis and C. parvum. For samples that failed to amplify or produced ambiguous banding  93 
patterns, a two-step nested PCR and sequencing of a ~540bp product the 18S gene locus was  94 
carried out (Ryan et al., 2003).   95 
Cryptosporidium hominis and C. parvum positive samples were subtyped at the gp60  96 
gene locus using a two-step nested PCR that amplifies a ~830bp fragment (Strong et al., 2000;  97 
Sulaiman et al., 2005). Secondary PCR products were purified and sequenced as described by  98 
Ng et al., (2006).  99 
Multilocus sequence typing was carried out on a smaller number (n=13) of C. hominis  100 
and  C.  parvum  positive  clinical  human  isolates  at  the  MSC6-7  gene  locus  (serine  repeat  101 
antigen) and the CP47 gene locus (47-kDa protein) and subtypes were assigned according to  102 
Gatei et al., (2007). Briefly, at the MSC6-7 gene locus, subtypes were assigned based on the  103 
minisatellite  TGATGATGAT(G)GAACC(T)  in  the  repeat  region  and  single  nucleotide  104 
polymorphisms (SNPs) in the non-repeat region. For the CP47 gene locus, C. hominis was  105 
assigned as type I and classified based on the number of TAA repeats, (coded as A) and  106 
TGA/TAG  repeats,  (coded  as  G),  with  the  following  digit  showing  the  number  of  107 
trinucleotide repeats (Gatei et al., 2007). Isolates were selected for analysis at the MSC6-7  108 
and CP47 gene loci based on their gp60 subtype family; Ib (1), Id (3), Ie (2), Ig (3) and four  109 
IIa subtypes, A17G2R1 (1), A18G3R1 (2) and A19G4R1 (1). Amplification of both gene loci  110 
was carried out as described in Gatei et al. (2006).   111 
Nucleotide  sequences  were  analyzed  using  ChromasPro  version  2.3  112 
(http://www.technelysium.com.au)  and  aligned  using  ClustalW  (http://clustalw.genome.jp).  113 ACCEPTED MANUSCRIPT 
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Distance estimation was conducted using TREECON (Van de Peer and De Wachter, 1997),  114 
based  on  evolutionary  distances  calculated  with  the  Kimura-2  model  and  grouped  using  115 
Neighbour-Joining. Parsimony analysis was conducted using MEGA version 3.1 (MEGA3.1:  116 
Molecular Evolutionary Genetics Analysis software, Arizona State University, Tempe, AZ).  117 
The confidence of groupings was assessed by bootstrapping, using 1000 replicates.  118 
  119 
2.3 Statistical analysis  120 
  121 
 Statistical analysis was performed using SPSS 17.0 (Statistical Package for the Social  122 
Sciences) for Macintosh  OS  X (SPSS inc. Chicago, USA) to  determine if there was  any  123 
association between subtypes and within subtype families versus age, gender and clinical  124 
symptoms.   125 
  126 
3. Results  127 
  128 
3.1. Cryptosporidium species  129 
  130 
From the 254 samples received between May 2005 to March 2008, 248 samples were  131 
amplified at the 18S rRNA locus. Analysis identified 195/248 (78.6%) as C. hominis, 49/248  132 
(19.8%) as C. parvum and 4/248 (1.6%) as C. meleagridis (Table 1).    133 
Of the 77 positive specimens received in 2005/2006, 74 were amplified at the 18S  134 
rRNA  gene  locus.  Cryptosporidium  hominis  was  identified  in  62.2%  of  the  isolates,  C.  135 
parvum in 33.8% and C. meleagridis in 4.1% as (Table 1). Infection with C. hominis was the  136 
highest amongst patients aged 0-5 years in 87.2% of cases, compared to infection C. parvum  137 
and  C.  meleagridis,  in  10.3%  and  2.6%  of  cases  respectively  (Table  2).  Cases  of  138 
Cryptosporidium  were  more  prevalent  in  regional  areas  of  Western  Australia  at  81.2%  139 ACCEPTED MANUSCRIPT 
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compared to urban areas at 18.8%, of which C. hominis was identified in 90.9% of these cases  140 
(Table 3).   141 
In 2006/2007, a total of 107/109 isolates received were amplified at the 18S rRNA  142 
gene locus, with 90.7% of the isolates identified as C. hominis, 8.4% as C. parvum and 0.9%  143 
as  C.  meleagridis  (Table  1).  Cryptosporidium  hominis  was  most  prevalent  across  all  age  144 
groups, of which 60.2% of cases were from the age group 0-5, 21.2% from 16-39 years and  145 
6.8% and 3.9% respectively for 6-15 and >40years. The single C. meleagridis case identified,  146 
was from the 16-39 age group (Table 2). There were a higher number of Cryptosporidium  147 
cases from regional areas of Western Australia (80.6%), compared to urban areas (19.4%),  148 
with C. hominis infection identified in 85% of urban and 94% of regional cases respectively  149 
(Table 3).   150 
From the 68 isolates received in 2007/2008, 67 isolates successfully amplified at the  151 
18S rRNA gene locus, of which C. hominis was identified in 77.6% of the samples and C.  152 
parvum in 22.4% of the samples. No C. meleagridis were identified from specimens received  153 
in this year. Most cases (60.7%) were from patients aged 5 and below and of these, 94.1%  154 
were  C.  hominis.  The  majority  of  specimens  received  were  from  regional  areas,  with  C.  155 
hominis being more prevalent than C. parvum in regional areas (90% of cases) (Table 3).  156 
  157 
3.2. Gp60 Sub-genotyping of C. hominis and C. parvum  158 
  159 
A total of 243 isolates, previously typed at the 18S locus, were successfully sub-typed  160 
at the gp60 locus. Representative sequences from each subtype were deposited in GenBank  161 
under the accession nos. GU933438-GU933458. The four C. meleagridis and one C. hominis  162 
isolates failed to amplify at the gp60 gene locus. A total of five C. hominis subtype families,  163 
Ib (39/243), Id (88/243), Ie (4/243), If (3/243) and Ig (60/243), and two C. parvum subtype  164 
families, IIa (48/243) and IId (1/243) were identified. Within the subtype families, two Id  165 ACCEPTED MANUSCRIPT 
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subtypes (IdA15G1 and IdA16), two Ig subtypes (IgA17 and IgA19) and five different IIa  166 
subtypes  (IIaA17G2R1,  IIaA18G3R1,  IIaA19G4R1,  IIaA20G3R1  and  IIaA21G3R1)  were  167 
identified (Table 4 and Figure 1a). The most common C. hominis subtype identified was the  168 
IdA15G1 subtype in 45.1% of the C. hominis positive isolates, followed by the IgA17 subtype  169 
(30.3%) and the IbA10G2 in 20% of the isolates. The IIaA18G3R1 subtype was the most  170 
common C. parvum subtype (65.3%) identified. The distribution of the four most common  171 
subtype familes identified in this study (Ib, Id, Ig and IIa), were analysed to determine if there  172 
were any association between these subtype familes and age and gender. Data for age range  173 
were grouped into those aged 5 and below and those above 5 years of age. Results showed  174 
that  patients  aged  5  and  below  were  more  likely  to  be  infected  with  subtype  familes  Id  175 
(RR1.91; 95% CI, 1.7-2.89; p<0.05) and Ig (RR 1.88; 95% CI, 1.10-3.24; p<0.05) compared  176 
to patients that are infected with these subtypes in the group age 5 and above. For the Ib  177 
subtype family, infection was more likely in individuals above 5 years of age (RR 0.63; 95%  178 
CI  0.35-1.12;  p>0.05).  Infection  with  the  IIa  subtype  family  was  also  more  likely  in  179 
individuals above 5 years of age (RR 0.2; 95% CI 0.09-4.0; p>0.05) compared to children  180 
aged 5 and below. There was no association between gp60 subtypes and gender.  181 
  182 
3.3. Multilocus Sequence Typing of C. hominis and C. parvum  183 
  184 
Sequence analysis of the CP47 gene of nine C. hominis isolates belonging to five  185 
different gp60 subtype families, identified five different C. hominis CP47 subtypes; IA38G21,  186 
IA42G25, IA44G28, IA46G30 and IA47G29 (Figure 1b). The gp60 subtypes analysed could  187 
be  differentiated  into  corresponding  CP47  subtypes,  with  the  exception  of  two  gp60  188 
IeA11G3T3 subtype isolates (H232 and H260), which formed two different CP47 subtypes.  189 
At  the  CP47  locus,  the  C.  parvum  gp60  subtypes  IIaA17G2R1  and  IIaA18G3R1  were  190 
identical but subtype IIaA19G4R1 (H236) exhibited differences. At the MSC6-7 gene locus,  191 ACCEPTED MANUSCRIPT 
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analysis of the nine C. hominis isolates showed length polymorphism: one 470 bp (H260),  192 
three 471bp (H164, H193, H232), one 472bp (H250), one 480bp (H172), two 495bp (H196,  193 
H226) and one 496bp (H209). Phylogenetic analysis of the MSC6-7 locus produced three  194 
groups,  with  isolates  H209  (gp60  subtype  IbA10G2)  and  H250  (gp60  subtype  IdA15G1)  195 
grouped together and separate from all other  C. hominis isolates (Figure 1c). All four C.  196 
parvum isolates were identical with isolate H236 showing only a 1bp difference at this locus.  197 
Both the CP47 and MSC6-7 gene loci were less variable than the gp60 locus. Analysis of  198 
concatenated sequences from the CP47, MSC6-7 and gp60 gene loci identified five groups,  199 
three of which corresponded to gp60 subtype groups IgA17, IeA11G3T3 and the C. parvum  200 
IIa subtypes (Figure 1a; 1d). Of the two remaining groups, one consisted of two gp60 subtype  201 
IdA15G1 isolates, while the other was formed by isolates H250 (gp60 subtype IdA15G1) and  202 
isolate H209 (gp60 subtype 1dA15G1) (Figure 1d).  203 
Nucleotide sequences for CP47 sequences have been deposited in GenBank under the  204 
accession  nos.  GU933459-GU933471  and  for  MSC6-7  sequences,  under  the  GenBank  205 
accession nos. GU933472-GU933484.  206 
  207 ACCEPTED MANUSCRIPT 
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3.4. Clinical symptoms  208 
  209 
Data  for  clinical  symptoms  reported  were  available  for  169  of  the  248  samples  210 
genotyped. Diarrhoea was the most common symptom reported in 72.1% of cases. This was  211 
followed by abdominal pain in 17.8% of cases, vomiting in 10.7%, failure to thrive in 4.1%,  212 
pneumonia in 2.5%, weight loss in 1.8%, muscle aches in 1.2% and fever and lethargy in  213 
0.6% each of cases. Recurrent infection of cryptosporidiosis was reported in 3.0% of cases  214 
while one case had a concurrent Salmonella infection. Overall, 18.3% reported more than one  215 
clinical symptom.   216 
The Id subtype family was associated with abdominal pain (p<0.05). No association  217 
was observed between diarrhoea and vomiting and infection with the  C. hominis subtype  218 
families Ib, Id or Ig (p>0.05).   219 
  220 
  221 
  222 
4. Discussion  223 
  224 
Results  revealed  that  anthroponotic  transmission  of  Cryptosporidium  is  common  225 
amongst WA humans, similar to reports from previous studies where the prevalence of C.  226 
hominis in Cryptosporidium positive samples from WA was 83% and 82% (Morgan et al.,  227 
1998; O’Brien et al., 2008). Findings from the present study also showed that C. hominis was  228 
most prevalent followed by C. parvum and C. meleagridis, corresponding to reports from  229 
studies conducted in SA, VIC and NSW which have also reported C. hominis as the most  230 
common species in sporadic cryptosporidiosis cases (Chalmers et al., 2005; Jex et al., 2007;  231 
Jex et al., 2008; Pangasa et al., 2009; Waldron et al., 2009b). Previous studies have reported  232 
that C. hominis was more prevalent in urban areas and C. parvum was more prevalent in  233 ACCEPTED MANUSCRIPT 
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regional areas (McLauchlin et al., 2000; Learmouth et al., 2004; Feltus et al., 2006; Zintl et  234 
al., 2009). Recent studies in NSW, reported that C. parvum was detected in higher proportions  235 
in sporadic cryptosporidiosis cases in regional NSW and in urban areas in and around Sydney,  236 
with similar prevalence of ~57% (Ng et al., 2008; Alagappan et al., 2009), whereas, in another  237 
study on sporadic cases in NSW, equal distributions of C. hominis and C. parvum among  238 
urban and regional areas was reported (Waldron et al., 2009a). In the present study however,  239 
C. hominis was found to be much more prevalent than C. parvum in both urban and regional  240 
WA, suggesting that there may be distinct geographical differences in the prevalence and  241 
transmission of C. hominis and C. parvum within Australia.   242 
The zoonotic C. meleagridis is recognised as the third most common Cryptosporidium  243 
species found in humans, and in some places, is found to be as prevalent as C. parvum (Xiao  244 
and  Feng,  2008).  Cryptosporidium  meleagridis  is  usually  identified  in  children  and  245 
immunocompromised  adults  from  developing  and  industrialised  countries  (Morgan  et  al.,  246 
2000; Guyot et al., 2001; Gatei et al., 2002; Alves et al., 2006). In the present study, C.  247 
meleagridis was identified in 4/248 of the WA clinical isolates. Of these, one was from a 3- 248 
year old child and three were from the 18-40 years age range, one of which was from a patient  249 
with chronic myeloid leukaemia. Epidemiological data showed reports of diarrhoea in all four  250 
cases, with one adult experiencing diarrhoea and fever. Cryptosporidium meleagridis has been  251 
reported in a wide range of avian hosts (Ryan, 2010), but was not identified in a study of  252 
Cryptosporidium species in birds in WA (Ng et al., 2006). Hence, although birds may play a  253 
role in the transmission of C. meleagridis, human to human transmission appears to be the  254 
more  likely  transmission  mode.  Cryptosporidium  meleagridis  has  been  identified  in  two  255 
separate studies of sporadic cases of cryptosporidiosis in VIC (Jex et al., 2007; Pangasa et al.,  256 
2009).  257 
Seasonal  trends  in  the  distribution  of  C.  hominis  and  C.  parvum  cases  have  been  258 
reported in the United Kingdom and New Zealand, with cases of cryptosporidiosis reported in  259 ACCEPTED MANUSCRIPT 
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spring mostly due to C. parvum and cases reported in autumn mainly due to  C. hominis  260 
infection (McLauchlin et al., 2000; Goh et al., 2004). In the present study, no definite trends  261 
were observed, with the number of cases due to C. hominis more prevalent than C. parvum  262 
across all seasons from 2005-2008 (Figure 2). The number of cases appeared to increase from  263 
spring  and  peaked  in  autumn  with  a  pronounced  peak  observed  in  the  autumn  of  2007  264 
following an outbreak (Ng et al., 2010). An equal proportion of IbA10G2 and IdA15G1 gp60  265 
subtypes were identified from cases in autumn 2007 (Table 5). However, in the present study,  266 
the majority of isolates typed were from rural locations whereas genotyping of the urban- 267 
derived Cryptosporidium isolates attributed to the 2007 outbreak were mostly identified as the  268 
IbA10G2 subtype (Ng et al., 2010).   269 
Cryptosporidium hominis and C. parvum heterogeneity was observed at the gp60 gene  270 
locus with 14 subtypes from 7 subtype families identified among positive WA human isolates  271 
(Table 4). The Ib subtype family has been reported as the most common C. hominis subtype  272 
identified in Australia (Jex, et al., 2007; 2008; Waldron, et al., 2009a; 2009b). However, in  273 
the present study, the Id subtype family was the most dominant subtype identified. The Id  274 
subtype family has been reported in developing countries such as South Africa, China, India  275 
and Malawi (Leav et al., 2002; Peng et al., 2001; 2003b; Gatei et al., 2007).   276 
There  appeared  to  be  an  association  between  the  two  most  common  subtypes  277 
identified in the present study; IdA15G1 and IgA17, in individuals aged 5 years and below  278 
Previous studies have shown that infection with the Id subtype family was associated with  279 
general and chronic diarrhoea and was the most virulent subtype in HIV-infected patients  280 
(Cama et al., 2007; 2008). In the present study, among those infected with the Id subtype  281 
family, 84.4% (54/64) reported diarrhoea with no indication of the length or severity and  282 
7.8% (5/64) of cases reported diarrhoea and vomiting. In general, diarrhoea was the most  283 
common clinical symptom reported, in all subtype families identified, except for the Ie and  284 
IId subtype families where no data for clinical symptoms were available. Data for clinical  285 ACCEPTED MANUSCRIPT 
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symptoms in the present study was however inadequate to generate statistically significant  286 
associations within subtype families and clinical symptoms. Future studies should include  287 
consistent  description  of  symptoms  or  case  definitions,  which  will  allow  for  better  288 
categorisation of data.   289 
For those infected with IgA17, 87% (40/46) of cases reported diarrhoea with 8.7%  290 
(4/46) of cases reported diarrhoea and vomiting. The severity and length of these symptoms  291 
however, were not available. The prevalence of Ig was consistent in 2005/06 and 2006/07 at  292 
31%  and  30.5%  respectively  but  for  2007/08,  the  prevalence  of  Ig  was  only  9.0%.  The  293 
numbers of the Ig subtype family identified in samples received were fairly consistent across  294 
the seasons, peaking in autumn 2006. However, from summer 2007, there was an increase in  295 
the number of Ib and Id isolates identified, which peaked in equal numbers in autumn 2007,  296 
following  the  WA  outbreak  (Ng  et  al.,  2010).  The  increase  in  the  presence  of  the  more  297 
virulent subtype families, such as the Ib subtype family, has been associated with a number of  298 
waterborne outbreaks worldwide (Zhou et al., 2003; Cohen et al., 2006; Leoni et al., 2007).  299 
The Ig subtype family has previously been reported in sporadic cases of cryptosporidiosis  300 
during a drinking-water associated outbreak in Northern Ireland (Glaberman et al., 2002) but  301 
was not identified in a more recent study on the prevalence of Cryptosporidium in humans in  302 
Ireland (Zintl et al., 2009).   303 
Subtyping studies have identified some C. parvum subtypes that have only been found  304 
in humans (Sulaiman et al., 2005; Alves et al., 2006; Trotz-Williams et al., 2006), refuting  305 
previous  assumptions  that  all  C.  parvum  infections  in  humans  were  due  to  zoonotic  306 
transmission.  The  two  most  common  C.  parvum  subtypes  families  identified  are  the  IIa  307 
subtype family, which have been identified in humans and ruminants and are responsible for  308 
the majority of zoonotic transmission in sporadic cases of cryptosporidiosis in humans, and  309 
the IIc subtype family, which has so far only been identified in humans (Xiao, 2010).   310 ACCEPTED MANUSCRIPT 
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In the present study, all cases with C. parvum were attributed to infection with the IIa  311 
subtype family, except for one case where the IId subtype was identified (Table 4). Within the  312 
IIa subtype family, five subtypes were identified, of which the IIaA18G3R1 subtype was the  313 
most  common  subtype  identified,  in  66.7%  of  cases  with  IIa  infection  (Table  4).  The  314 
IIaA18G3R1 subtype is one of the most commonly reported C. parvum subtype in humans  315 
and cattle in Australia and Ireland (Thompson et al., 2007; O’Brien et al., 2008; Ng et al.,  316 
2008; Jex et al., 2008; Zintl et al., 2009; Waldron et al., 2009a; 2009b). The other subtypes  317 
identified  in  the  present  study;  IIaA17G2R1,  IIaA20G3R1  and  IIaA21G2R1,  were  also  318 
detected  in  NSW  cattle  and  cattle  in  Ireland  (Thompson  et  al.,  2007;  Ng  et  al.,  2008),  319 
implicating the importance of the role of ruminants in the zoonotic transmission of the C.  320 
parvum IIa subtype family.  321 
The IId subtype family is relatively rare but has been reported in humans and cattle in  322 
Portugal (Alves et al., 2003; 2006), cattle in Hungary (Plutzer and Karanis, 2007), lambs and  323 
goats  in  Spain  (Quilez et  al.,  2008) and humans in  Ireland, Kuwait, the Netherlands and  324 
Australia (Sulaiman et al., 2005; Wielinga et al., 2008; Zintl et al., 2009; Waldron et al.,  325 
2009b). IId subtypes of C. parvum have never been found in humans or calves in the United  326 
States  and  Canada  (Xiao,  2010).  In  the  present  study,  the  one  IId  subtype  identified,  327 
IIdA15G1, was from a 3-year old from an urban area in WA. To date, no subtypes from the  328 
IId family have been identified in any animals in Australia. In the Netherlands, the IId subtype  329 
family,  including  the  IIdA15G1  subtype,  was  only  identified  in  humans  and  not  in  farm  330 
animals (Wielinga et al., 2008). More genotyping studies need to be carried out in order to  331 
understand and assess the transmission route for this subtype.   332 
 Across Australia, subtyping of the gp60 gene has been used to study cases of sporadic  333 
human and cattle cryptosporidiosis in four different states (WA, SA, VIC and NSW). These  334 
studies have shown that Australia harbours a total of six different C. hominis gp60 subtype  335 
families  and  only  three  different  C.  parvum  gp60  subtype  families  with  WA  and  NSW  336 ACCEPTED MANUSCRIPT 
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showing higher subtype heterogeneity than VIC and SA (Table 6). Up to 15 subtypes from six  337 
different gp60 subtype families have been identified in WA whilst NSW have reported 12  338 
subtypes from five different subtype families. Within Australia, large subtype heterogeneity  339 
has been observed in C. hominis gp60 Ib and Id subtype families, with eight and six subtypes  340 
in each respective family. For the Ib subtype family however, only the IbA10G2 subtype was  341 
identified across the four different states with a prevalence ranging from 16% (in WA) to  342 
97.3% (in VIC) and has been implicated as the cause of a recent outbreak in NSW (Waldron  343 
and  Power,  2009).  Three  different  C.  parvum  subtype  families  have  been  identified  in  344 
Australia; IIa, IIc and IId. Both the IIa subtype family (which was the most common subtype  345 
identified across all states) and the anthroponotic IIc subtype family have been reported in all  346 
four states, whereas the IId subtype family has only been identified in WA (1 IIdA15G1  347 
subtype) and NSW (1 IIdA24G1 subtype) (Table 6). The IIa subtype family exhibited the  348 
highest level of genetic heterogeneity with a total of 16 different subtypes identified across  349 
Australia. Large heterogeneity amongst IIa subtypes however, is not uncommon and has been  350 
observed in studies of C. parvum infected humans in Ireland and cattle in the Netherlands  351 
(Wielinga et al., 2008; Zintl et al., 2009). IIaA18G3R1 is the most common IIa subtype and  352 
has been identified in cases from humans in WA, SA, VIC and NSW and cases from cattle in  353 
WA  and  NSW.  Other  IIa  subtypes  such  as  IIaA15G2R1,  IIaA16G3R1,  IIaA17G2R1,  354 
IIaA19G4R1  and  IIaA20G3R1  have  been  identified  in  both  human  and  cattle  cases  in  355 
Australia, implicating the potential role of cattle in the zoonotic transmission of C. parvum.   356 
Multilocus  sequence  typing  (MLST)  and  multilocus  typing  (MLT)  studies  have  357 
identified distinct C. hominis subtypes from different geographical locations and the type of  358 
Cryptosporidium populations within countries (Mallon et al., 2003a; 2003b; Ngouanesavanh  359 
et al., 2006; Gatei et al., 2006; 2007; 2008). In the present study, two additional gene loci  360 
were analysed; CP47 and MSC6-7. The CP47 locus is a 47kDa protein gene and subtypes are  361 
defined based on differences within its microsatellite region. The MSC6-7 locus is a serine  362 ACCEPTED MANUSCRIPT 
  16 
repeat antigen gene and typing is based on SNP differences in minisatellite repeats and in the  363 
non-minisatellite region. Both these genes have previously been shown to exhibit high DNA  364 
sequence diversity and have been used to identify genetic differences between C. hominis  365 
isolates from different countries (Gatei et al., 2006; 2007; 2008).   366 
In the present study, sequence typing and phylogenetic analysis showed that all gp60  367 
subtypes  analysed  could  be  differentiated  into  corresponding  CP47  subtypes,  with  the  368 
exception of two gp60 IeA11G3T3 subtype isolates (H232 and H260), which formed two  369 
different  CP47  subtypes  (Figure  1b).  At  the  MSC6-7  gene  locus  however,  phylogenetic  370 
analysis showed that all three IgA17 subtype isolates (H172, H196, H226) formed a single  371 
group, although based on the MSC6-7 sequence length polymorphism, a 15bp length variation  372 
was noted for one of the three IgA17 subtype isolate (H172). Interestingly, two very different  373 
gp60  subtype  families;  isolates  H209  (gp60  subtype  IbA10G2)  and  H250  (gp60  subtype  374 
IdA15G1)  grouped  together  at  the  MSC6-7  and  were  separate  from  all  other  C.  hominis  375 
isolates  (Figure  1c).  Application  of  the  MLST  tool  may  be  useful  in  elucidating  and  376 
comparing  the  population  structures  and  transmission  of  Cryptosporidium  from  different  377 
geographical locations. There is however, a paucity of sequences for the CP47 and MSC6-7  378 
loci in GenBank, which makes comparison between gp60 subtypes and CP47 and MSC6-7  379 
subtypes difficult. Increased application of these MLST tools will lead to more sequences  380 
being deposited in GenBank, which will be useful for future transmission and population  381 
studies of this ubiquitous parasite.   382 
Anthroponotic  transmission  of  C.  hominis  among  humans  is  the  main  mode  of  383 
transmission in WA as it was the dominant species identified in isolates from both urban and  384 
rural areas of WA. Regular surveillance of cryptosporidiosis in rural regions may assist in  385 
understanding the transmission dynamics of C. hominis in these areas and the implementation  386 
of better control measures. Zoonotic transmission of Cryptosporidium however, should not be  387 
underestimated. Cattle may play an important role in the transmission of C. parvum as C.  388 ACCEPTED MANUSCRIPT 
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parvum  gp60  subtypes,  which  have  been  previously  reported  in  cattle,  were  identified  in  389 
humans in the present study. Larger studies of Australian cattle and sheep populations are  390 
required to determine the extent of their role in zoonotic transmission of Cryptosporidium.  391 
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  26 
Figure 1: Phylogenetic inference of C. hominis and C. parvum gp60, MLST sequences CP47  590 
and MSC 6-7 gene using Kimura-2 distance calculation model. Bootstrap support values from  591 
1000 replicates are represented as percentage number at branch internodes. (a) Neighbour  592 
joining  analysis  at  the  gp60  gene  locus  with  subtypes  listed  after  the  isolate  code  no  in  593 
brackets; (b) Neighbour joining analysis at the CP47 gene locus. CP47 subtypes are listed  594 
after the isolate code no and gp60 subtypes of the isolates are listed in brackets; (c) Neighbour  595 
joining analysis at the MSC6-7 gene locus; and (d) Neighbour joining consensus tree based on  596 
concatenated gp60, CP47 and MSC6-7 gene sequences.  597 
  598 
  599 
  600 
Figure 2: Seasonal distribution of C. hominis and C. parvum and the total number of cases  601 
reported in Western Australia in 2005, 2006, 2007 and 2008.  602 
  603 
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Table 1: Cryptosporidium species identified per yearly range from May 2005 to March 2008. 
  Yearly range 
  May2005-Mar2006  Apr2006-Mar2007  Apr2007-Mar2008 
C. hominis  46  97  52 
C. parvum  25  9  15 
C. meleagridis  3  1  0 
Total  74  107  67 
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Table 2. Distribution of Cryptosporidium species in Western Australian humans by age.   
Age Range 
(yrs.) 
 
% 
 
Species 
C. hominis  C. parvum  C. meleagridis 
2005/2006 (n=71
 a)
  
<5  54.9  34  4  1 
6-15  18.3  6  6  0 
16-39  14.1  3  6  1 
40-90  12.7  1  5  1 
Total    44  21  3 
2006/2007 (n =103
 b) 
<5  63.1  62  3  0 
6-15  7.8  7  1  0 
16-39  24.3  22  2  1 
40-90  4.9  4  1  0 
Total    95  7  1 
2007/2008 (n=56
 c) 
<5  60.7  32  2  0 
6-15  7.1  3  1  0 
16-39  19.6  9  2  0 
40-90  12.5  2  5  0 
Total    46  10  0 
a = For 2005/2006, data of patient’s age was only available for 71 of the 74 isolates amplified 
b = For 2006/2007, data of patient’s age was only available for 103 of the 107 isolates amplified
 
c = For 2007/2008, data of patient’s age was only available for 56 of the 67 isolates amplified 
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Table 3: Distribution of Cryptosporidium species in Western Australian humans in urban and 
regional areas.  
  2005/2006
a  2006/2007
b  2007/2008
c 
Urban  Regional  Urban  Regional  Urban  Regional 
C. hominis  4  40  17  78  10  36 
C. parvum  8  14  3  4  1  4 
C. meleagridis  1  2  0  1  0  0 
a = For 2005/2006, data for area of patient’s location was only available for 69 of the 74 isolates amplified 
b = For 2006/2007, data for area of patient’s location available for 103 of the 107 isolates amplified
 
c = For 2007/2008, data for area of patient’s location available for 51 of the 67 isolates amplified 
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Table  4:  Cryptosporidium  hominis  and  C.  parvum  GP60  subtypes  identified  in  Western 
Australian humans from 2005-2008. 
 
 
Subtype 
Family  Subtype  2005/2006  2006/2007  2007/2008  Total 
C. hominis 
Ib  A10G2  1  17  21  39 
Id  A15G1  19  43  24  86 
A16  0  2  0  2 
Ie 
A11G3T3  2  1  0  3 
A12G3T3  0  0  1  1 
If  A12G1  2  1  0  3 
Ig  A17  22  32  5  59 
A19  0  0  1  1 
C. parvum 
IIa 
A17G2R1  8  1  2  11 
A18G3R1  14  7  11  32 
A19G4R1  2  1  0  3 
A20G3R1  0  0  1  1 
A21G2R1  1  0  0  1 
IId  A15G1  0  0  1  1 
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Table 5: Seasonal distribution of Cryptosporidium GP60 subtype families and subtypes  in Western Australia humans. Months of the season in 
Australia – Summer, December-February, Autumn, March-May, Winter, June – August, Spring, September –November. 
  Subtype 
Family  Subtype 
Autumn, 
May 
2005 
Winter 
2005 
Spring 
2005 
Summer 
2005/06 
Autumn 
2006 
Winter 
2006 
Spring 
2006 
Summer 
2006/07 
Autumn 
2007 
Winter 
2007 
Spring 
2007 
Summer 
2007/08 
Autumn, 
March 
2008 
C. hominis 
(n=195)* 
Ib  A10G2  -  -  -  1  3  1  1  3  28  1  1  -  - 
Id 
 
A15G1  5  3  2  5  7  3  9  15  28  1  3  5  - 
A16  -  -  -  -  -  -  -  2  -  -  -  -  - 
Ie 
 
A11G3T3  -  -  -  1  2  -  -  -  -  -  -  -  - 
A12G3T3  -  -  -  -  -  -  -  -  -  -  -  -  1 
If  A12G1  -  -  -  2  -  -  -  1  -  -  -  -  - 
Ig 
 
A17  1  7  6  7  16  2  4  6  7  1  1  1  - 
A19  -  -  -  -  -  -  -  -  -  -  -  -  1 
C. parvum 
(n=49) 
IIa 
 
 
 
 
A17G2R1  -  4  1  3  -  1  -  -  -  -  -  2  - 
A18G3R1  1  6  1  6  2  4  1  -  2  -  4  4  1 
A19G4R1  -  -  -  1  2  -  -  -  -  -  -  -  - 
A20G3R1  -  -  -  -  -  -  -  -  -  -  1  -  - 
A21G2R1  1  -  -  -  -  -  -  -  -  -  -  -  - 
IId  A15G1  -  -  -  -  -  -  -  -  -  -  -  1  - 
C. meleagridis 
(n=4) 
    -  1  1  1  -  1  -  -  -  -  -  -  - 
*one isolate, positive at the 18S rRNA gene locus did not amplify at the GP60 gene locus. 
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Table 6: Summary of GP60 subtypes identified in humans and cattle in Australia and the 
number of isolates identified per species in each study. 
Host  Species  Sub-subtypes  Western Australia  New South Wales  Victoria  South Australia 
Human 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. hominis 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
IaA10R4    1/37
6  -  - 
IaA17R1  -  -  -  3/38
3 
IaA17R3  -  1/37
6  -  - 
IaA23  1/41
5  -  -  - 
IbA5G2T3  1/41
5  -  -  - 
IbA6G3  -  1/37
6  -  - 
IbA9G2  1/41
5  2/37
6  -  - 
IbA9G2T1  1/41
5  -  -  - 
IbA9G2  1/41
5  2/37
6  -  - 
IbA9G3  -  -  -  7/22
1;14/38
3 
IbA10G2  21/41
5;40/197
7  2/23
4; 25/37
6  72/74
2  20/38
3 
IbA18G1  -  -  1/74
2  - 
IdA15  -  1/37
6  -  - 
IdA15G1  9/41
5; 88/197
7  1/37
4  1/74
2  - 
IdA16  1/41
5; 2/197
7  -  -  - 
IdA24T1  -  1/37
6  -  - 
IdA25  3/41
5  -  -  - 
IdA26  -  1/37
6  -  - 
IeA11G3T3  3/197
7  1/37
6  -  - 
IeA12G3T3  1/197
7  -  -  - 
IfA11G1T1  1/41
5  -  -  - 
IfA12G1  2/41
5; 4/197
7  1/37
6  -  1/38
3 
IgA17  58/197
7  -  -  - 
IgA19  1/197
7  -  -  - 
Human 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
C. parvum 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
IIaA15G2R1  2/7
5  1/32
6  -  - 
IIaA16G3R1  -  2/32
6  -  - 
IIaA16G4R1  -  1/32
6  -  - 
IIaA17G2R1  1/7
5; 11/49
7  1/4
4; 1/32
6  -  - 
IIaA17G3R1  -  1/32
6  -  - 
IIaA17G4R1  -  1/32
6  -  - 
IIaA18G3R1  3/7
5; 32/49
7  1/4
4; 10/32
6  9/23
2  15/24
3 
IIaA19G3R1  1/7
5  1/4
4; 1/32
6  -  - 
IIaA19G4R1  1/7
5; 3/49
7  -  -  - 
IIaA20G2R1  -  1/32
6  7/23
2  6/24
3 
IIaA20G3R1  1/49
7  1/4
4; 1/32
6  -  - 
IIaA20G5R1  -  3/32
6  -  - 
IIaA21G2R1  1/49
7  -  -  - 
IIaA22G3R1  -  1/32
6  1/23
2  - 
IIaA22G4R1  -  -  -  2/24
3 
IIaA23G3R1  -  -  1/23
2  - 
IIcA5G3a  1/7
5  1/7
6  5/23
2  1/24
3 
IIdA15G1  1/49
7  -  -  - 
IIdA24G1  -  1/32
6  -  - 
Cattle 
  
  
  
  
  
  
C. parvum 
  
  
  
  
  
  
IIaA15G2R1  2/7
5  -  -  - 
IIaA16G3R1  -  3/13
4  -  - 
IIaA17G2R1  -  1/13
4  -  - 
IIaA18G3R1  5/7
5  5/13
4  -  - 
IIaA19G4R1  -  2/13
4  -  - 
IIaA20G3R1  -  1/13
4  -  - 
IIaA21G3R1  -  1/13
4  -  - 
Superscript denotes the reference study where the subtypes were identified: 
1Chalmers et al 2005; 
2Jex et al., 
2007; 
3Jex et al., 2008; 
4Ng et al., 2008; 
5O’Brien et al., 2008; 
6Waldron et al., 2009b; 
7The present study. 
*NB: The gp60 subtype nomenclature used by Jex et al., (2007; 2008) includes some non-serine-coding 
sequences in the microsatellite repeat number counting, which has caused confusion and is not generally 
accepted by other researchers. Therefore, the data from SA in Table 6 are based on the accepted subtype 
nomenclature. 
 